Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of Ciclesonide HFA in PAR
NCT01067105Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Feb 2010
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in perennial allergic rhinitis (PAR), sponsored by Sumitomo Pharma America. Started Feb 2010; status: completed.
02
Drugs
ciclesonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01067105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067105.